Remicade® (infliximab) now Licensed for Paediatric Patients with Ulcerative ... PharmiWeb.com (press release) ... in paediatric patients aged 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies. |
